Publication | Closed Access

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

VaccinationSubtypes AVaccine TargetHuman RetrovirusImmunologyAntiviral ResponseVirologyProtein Boosting ApproachHivImmunotherapyMedicinePolyvalent VaccineVaccine Design